{
    "organizations": [],
    "uuid": "0b8a156a1401fc9bde9e7ce13d2f87bf2c3bf0b3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-armo-biosciences-enrolls-patient-i/brief-armo-biosciences-enrolls-patient-in-the-cypress-2-trial-evaluating-am0010-idUSFWN1RB0GL",
    "ord_in_thread": 0,
    "title": "BRIEF-Armo Biosciences Enrolls Patient In The Cypress 2 Trial Evaluating AM0010",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Armo Biosciences Inc:\n* ARMO BIOSCIENCES ENROLLS FIRST PATIENT IN THE CYPRESS 2 TRIAL EVALUATING AM0010 IN NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T20:02:00.000+03:00",
    "crawled": "2018-03-29T15:11:05.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "armo",
        "bioscience",
        "inc",
        "armo",
        "bioscience",
        "enrolls",
        "first",
        "patient",
        "cypress",
        "trial",
        "evaluating",
        "am0010",
        "cell",
        "lung",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}